SCWORX CORP (WORX) Fundamental Analysis & Valuation
NASDAQ:WORX • US78396V2088
Current stock price
0.1287 USD
+0 (+1.5%)
At close:
0.129 USD
+0 (+0.23%)
After Hours:
This WORX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. WORX Profitability Analysis
1.1 Basic Checks
- In the past year WORX has reported negative net income.
- WORX had a negative operating cash flow in the past year.
- In the past 5 years WORX always reported negative net income.
- WORX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- WORX has a Return On Assets of -54.21%. This is amonst the worse of the industry: WORX underperforms 80.00% of its industry peers.
- WORX has a worse Return On Equity (-64.87%) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -54.21% | ||
| ROE | -64.87% | ||
| ROIC | N/A |
ROA(3y)-33.77%
ROA(5y)-42.54%
ROE(3y)-51.97%
ROE(5y)-68.9%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of WORX (26.13%) is worse than 77.14% of its industry peers.
- WORX's Gross Margin has improved in the last couple of years.
- WORX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y3.43%
2. WORX Health Analysis
2.1 Basic Checks
- WORX has more shares outstanding than it did 1 year ago.
- WORX has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, WORX has an improved debt to assets ratio.
2.2 Solvency
- WORX has an Altman-Z score of -5.86. This is a bad value and indicates that WORX is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of WORX (-5.86) is worse than 77.14% of its industry peers.
- WORX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of WORX (0.00) is better than 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.86 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- WORX has a Current Ratio of 1.13. This is a normal value and indicates that WORX is financially healthy and should not expect problems in meeting its short term obligations.
- WORX's Current ratio of 1.13 is on the low side compared to the rest of the industry. WORX is outperformed by 74.29% of its industry peers.
- WORX has a Quick Ratio of 1.13. This is a normal value and indicates that WORX is financially healthy and should not expect problems in meeting its short term obligations.
- WORX has a Quick ratio of 1.13. This is in the lower half of the industry: WORX underperforms 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.13 |
3. WORX Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 65.24% over the past year.
- Looking at the last year, WORX shows a very negative growth in Revenue. The Revenue has decreased by -13.63% in the last year.
- Measured over the past years, WORX shows a very negative growth in Revenue. The Revenue has been decreasing by -11.64% on average per year.
EPS 1Y (TTM)65.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.28%
Revenue 1Y (TTM)-13.63%
Revenue growth 3Y-13.57%
Revenue growth 5Y-11.64%
Sales Q2Q%-6.54%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. WORX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for WORX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. WORX Dividend Analysis
5.1 Amount
- WORX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
WORX Fundamentals: All Metrics, Ratios and Statistics
0.1287
+0 (+1.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-30 2026-03-30
Inst Owners3.01%
Inst Owner Change15.49%
Ins Owners0.42%
Ins Owner Change0%
Market Cap2.04M
Revenue(TTM)2.78M
Net Income(TTM)-3.89M
Analysts0
Price TargetN/A
Short Float %8.24%
Short Ratio0.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.73 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.34 | ||
| P/tB | 13.14 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.18
BVpS0.38
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -54.21% | ||
| ROE | -64.87% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.13% | ||
| FCFM | N/A |
ROA(3y)-33.77%
ROA(5y)-42.54%
ROE(3y)-51.97%
ROE(5y)-68.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y3.43%
F-Score3
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | -5.86 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.63%
Revenue growth 3Y-13.57%
Revenue growth 5Y-11.64%
Sales Q2Q%-6.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.89%
OCF growth 3YN/A
OCF growth 5YN/A
SCWORX CORP / WORX Fundamental Analysis FAQ
What is the ChartMill fundamental rating of SCWORX CORP (WORX) stock?
ChartMill assigns a fundamental rating of 1 / 10 to WORX.
What is the valuation status for WORX stock?
ChartMill assigns a valuation rating of 0 / 10 to SCWORX CORP (WORX). This can be considered as Overvalued.
What is the profitability of WORX stock?
SCWORX CORP (WORX) has a profitability rating of 1 / 10.
Can you provide the financial health for WORX stock?
The financial health rating of SCWORX CORP (WORX) is 2 / 10.